Related references
Note: Only part of the references are listed.Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice
Mitchell Bijnen et al.
GUT (2018)
Role of miRNAs in lung cancer
Arif Uddin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma
Ailiang Zeng et al.
CELL DEATH & DISEASE (2018)
Single-Cell RNA-Sequencing in Glioma
Eli Johnson et al.
CURRENT ONCOLOGY REPORTS (2018)
miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas
Shouwei Li et al.
NEURO-ONCOLOGY (2017)
Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma
A-L Zeng et al.
ONCOGENE (2017)
A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke
Hsu-Tung Lee et al.
THERANOSTICS (2017)
Tumor Purity as an Underlying Key Factor in Glioma
Chuanbao Zhang et al.
CLINICAL CANCER RESEARCH (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer
Linjie Zhao et al.
CANCER RESEARCH (2017)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
Amanda Shea et al.
CANCER MEDICINE (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
miRNA Multiplayers in glioma. From bench to bedside
Katarzyna Rolle
ACTA BIOCHIMICA POLONICA (2015)
c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma
Hui Luo et al.
BRAIN (2015)
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway
Anwar Hossain et al.
STEM CELLS (2015)
CXCL14: the Swiss army knife chemokine
Charaf Benarafa et al.
ONCOTARGET (2015)
IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma
Ailiang Zeng et al.
ONCOTARGET (2015)
GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity
Alenoush Vartanian et al.
NEURO-ONCOLOGY (2014)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
Li Shi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2
Xie-Feng Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
CCL2 Blockade Augments Cancer Immunotherapy
Zvi G. Fridlender et al.
CANCER RESEARCH (2010)
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
Martin Augsten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
CXCL14 expression and potential function in pancreatic cancer
Moritz N. Wente et al.
CANCER LETTERS (2008)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Modulation of CXCL14 (BRAK) expression in prostate cancer
SR Schwarze et al.
PROSTATE (2005)
Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo
GV Shurin et al.
JOURNAL OF IMMUNOLOGY (2005)
CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo
N Lapteva et al.
CANCER GENE THERAPY (2005)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue
MJ Frederick et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
